The intersection of scientific research, evidence and expertise can be a dicey one, particularly in an age in which evidence-based medicine is replacing the clinical expertise of practitioners.
In The New York Times Sunday Review, Jamie Holmes wrote about how the challenge of assessing the quality of evidence against expertise and less stringently conducted research can lead readers to confusion and frustration. Continue reading
The new year heralds a new administration and much uncertainty about what lies ahead for older adults’ health care. There are threats (or promises) to privatize Medicare, cut elder-friendly programs such as the SNAP supplemental nutrition program, revamp Social Security, eliminate CMS demo programs and more.
From science to community-based care, here are some issues to put on your beat’s radar for 2017: Continue reading
Just one in every six new stories about medical research contained independent comments from someone besides the study authors — and a quarter of them did not have the relevant clinical or academic expertise to be commenting on the research. Further, just over half of those commenters had relevant conflicts of interest, but only half were reported in the news article. Those are the findings of a sobering, though unsurprising, new study that reveals just how much news consumers suffer from a dearth of high-quality reporting on medical research.
In plainer terms, health journalists need to be doing a better job when reporting on medical research. Continue reading
When it comes to social determinants and health, gender is one of the uncontrollable risk factors that can impact health. And while science still is exploring the extent of this impact, Consumer Reports recently examined six areas where differences have more clearly emerged.
These areas – colon cancer, heart attack, depression, smoking cessation, Alzheimer’s and Parkinson’s diseases – not only can have gender-specific symptoms but increasingly can benefit from more tailored care (including medication), according to Consumer Reports’ November On Health newsletter. Researchers also have begun to explore how gender affects pain and opioid use, it reported. Continue reading
The placebo effect presents quite the conundrum to researchers attempting to discern whether a particular intervention truly offers clinical benefit for patients. Those most susceptible to the effect can feel so much better after a placebo that their “improvement” exceeds that of others taking a chemically active drug.
This problem may slow down the pipeline for new effective drugs, Erik Vance suggests in his recent Washington Post article, “People susceptible to the placebo effect may be keeping us from getting new drugs.” Continue reading